P. Siegenthaler

发表

Phase II trial of Nimustine (ACNU; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride) in patients with small cell carcinoma of the lung after failure on combination chemotherapy

F. Cavalli, M. Castiglione, C. Ludwig, 2004, Investigational New Drugs.

Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) study.

H. Pinedo, G. Decoster, C. Ludwig, 1994, European journal of cancer.

Combined-modality treatment of small-cell lung cancer: Randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest

H. Senn, G. Martinelli, C. Ludwig, 1994 .

Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group.

F. Cavalli, M. van Glabbeke, H. Hansen, 1983, European journal of cancer & clinical oncology.

Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study.

J. Verweij, L. Dirix, D. Wagener, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of 9-hydroxy-2N-methylellipticinium acetate.

F. Cavalli, H. Hansen, A. Brugarolas, 1984, European Journal of Cancer and Clinical Oncology.

Phase-II study with cis-dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma.

F. Cavalli, A. Goldhirsch, M. Beer, 1980, European journal of cancer.

Virgilian Echoes in the Aenigmata Symposii: Two Unnoticed Technopaignia

P. Siegenthaler, C. Castelletti, 2016 .

Phase II study of 5′-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma

F. Cavalli, S. Gundersen, H. Pinedo, 2004, Cancer Chemotherapy and Pharmacology.

A phase II study of doxifluridine in patients with advanced breast cancer.

F. Cavalli, W. Jungi, G. Decoster, 1988, European journal of cancer & clinical oncology.

Phase II study of doxifluridine in advanced colorectal adenocarcinoma.

F. Cavalli, P. Alberto, E. Holdener, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.

F. Cavalli, H. Hansen, A. Brugarolas, 1979, European Journal of Cancer.

Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group.

F. Cavalli, H. Hansen, R. Sylvester, 1978, European journal of cancer.

Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole‐abdominal radiotherapy

R. Gelber, E. Dreher, A. Goldhirsch, 1988, Cancer.

Combination chemotherapy with mitomycin, vindesine, and cisplatin for non‐small cell lung cancer association of antitumor activity with initial tumor burden and treatment center

F. Cavalli, R. Stahel, H. Senn, 1990, Cancer.

Early versus late alternating chemotherapy in small-cell lung cancer

R. Stahel, C. Hürny, J. Bernhard, 1995 .

Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.

F. Cavalli, C. Sessa, R. Joss, 1985, Cancer treatment reports.

Phase II study of amsacrine in refractory lymphomas. A report of the EORTC Early Clinical Trials Group.

M. van Glabbeke, V. Bramwell, W. W. ten Bokkel Huinink, 1984, European journal of cancer & clinical oncology.

Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinoma.

H. Hansen, P. Dombernowsky, R. Somers, 1982, European journal of cancer & clinical oncology.

Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapy.

M. van Glabbeke, S. Monfardini, S. Gundersen, 1988, European journal of cancer & clinical oncology.

Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.

F. Cavalli, M. Castiglione, H. Senn, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial with Flavone Acetic Acid (NSC.347512, LM975) in patients with non-small cell lung cancer.

S. Monfardini, S. Kaye, P. Siegenthaler, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.

F. Cavalli, A. Goldhirsch, R. Joss, 1984, Cancer treatment reports.

Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).

R. Stahel, C. Hürny, J. Bernhard, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.